Home LiteratureArticle Details
PMID: 3539800 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Effect of acetylation on arthropathic activity of group A streptococcal peptidoglycan-polysaccharide fragments.

Infection and immunity ·Vol. 55 ·No. 1 ·1987-01-00 ·Pages 16-23

Stimpson SA, Lerch RA, Cleland DR, Yarnall DP, Clark RL, Cromartie WJ, Schwab JH

Abstract

Purified group A streptococcal peptidoglycan-polysaccharide (PG-PS) fragments were either de-O-acylated, or acetylated and then de-O-acylated to yield N-acetylated PG-PS. Native PG-PS was poorly degraded, N-acetylated PG-PS was extensively degraded, and de-O-acylated PG-PS was only slightly degraded by hen egg white lysozyme. N-acetylated PG-PS was also extensively degraded by human lysozyme and partially degraded by rat serum or rat liver extract. After a single intraperitoneal injection of rats with a sterile, aqueous suspension, all PG-PS preparations induced acute arthritis. The acute arthritis induced by N-acetylated PG-PS was significantly more severe than that induced by native PG-PS; that induced by de-O-acylated PG-PS was of intermediate severity. After the acute reaction, rats injected with native PG-PS developed chronic relapsing erosive synovitis which remained severe for the duration of the experiment (83 days). In contrast, joint inflammation induced by N-acetylated PG-PS resolved within 6 weeks with little evidence of recurrent disease. Chronic arthritis induced by de-O-acylated PG-PS was of intermediate severity. In another assay of arthropathic activity, the arthritis in all rat ankle joints, which had been injected directly with native PG-PS, could be reactivated 3 weeks later by the intravenous injection of a small dose of PG. In contrast, only 50% of the joints initially injected with de-O-acylated PG-PS and none of the joints injected with N-acetylated PG-PS could be reactivated. These studies support the concepts that the resistance of PG-PS to muralytic digestion is crucial for chronic arthropathic activity and that the nature and degree of PG acetylation are important molecular determinants of the phlogistic activities of PG-PS polymers.

MeSH Terms
Acetylation Animals Antigens, Bacterial/administration & dosage,immunology Arthritis/immunology Arthritis, Experimental/immunology Female Muramidase/metabolism Peptidoglycan/immunology,metabolism Polysaccharides, Bacterial/immunology,metabolism Rats Streptococcus pyogenes/immunology Structure-Activity Relationship
Chemicals
Antigens, Bacterial Peptidoglycan Polysaccharides, Bacterial Muramidase
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Stimpson S A
Lerch R A
Cleland D R
Yarnall D P
Clark R L
Cromartie W J
Schwab J H
References (41)
41 references, click to expand
  1. Rat arthritis due to whole group B streptococci. Clinical and histopathologic features compared with groups A and D.
    Am J Pathol. 1983 Jul;112(1):37-47 PMID: 6407330
  2. Development of lysozyme-resistance in Micrococcus lysodiekticus and its association with an increased O-acetyl content of the cell wall.
    Nature. 1958 Jun 28;181(4626):1783-4 PMID: 13566139
  3. Arthropathic properties of cell wall polymers from normal flora bacteria.
    Infect Immun. 1986 Jan;51(1):240-9 PMID: 3940996
  4. Strain and sex variation in the susceptibility to streptococcal cell wall-induced polyarthritis in the rat.
    Arthritis Rheum. 1982 Sep;25(9):1064-72 PMID: 7126290
  5. Arthritis in rats after systemic injection of streptococcal cells or cell walls.
    J Exp Med. 1977 Dec 1;146(6):1585-602 PMID: 336836
  6. In vivo degradation of bacterial cell wall by the muralytic enzyme mutanolysin.
    Infect Immun. 1986 May;52(2):459-67 PMID: 3516873
  7. Occurrence of N-nonsubstituted glucosamine residues in peptidoglycan of lysozyme-resistant cell walls from Bacillus cereus.
    J Biol Chem. 1972 Oct 10;247(19):6312-22 PMID: 4631319
  8. STRUCTURE OF STREPTOCOCCAL CELL WALLS. 3. CHARACTERIZATION OF AN ALANINE-CONTAINING GLUCOSAMINYLMURAMIC ACID DERIVATIVE LIBERATED BY LYSOZYME FROM STREPTOCOCCAL GLYCOPEPTIDE.
    J Biol Chem. 1964 Sep;239:2981-5 PMID: 14217885
  9. Lysis of grouped and ungrouped streptococci by lysozyme.
    Infect Immun. 1970 Nov;2(5):563-9 PMID: 16557878
  10. Biological properties of streptococcal cell-wall particles. 3. Dermonecrotic reaction to cell-wall mucopeptides.
    J Bacteriol. 1966 Jan;91(1):374-83 PMID: 4955252
  11. Degradation of streptococcal cell wall antigens in vivo.
    J Bacteriol. 1967 Nov;94(5):1346-52 PMID: 6057793
  12. Degradation of group A streptococcal cell walls by egg-white lysozyme and human lysosomal enzymes.
    Infect Immun. 1972 Sep;6(3):403-13 PMID: 4564894
  13. Effect of leukocyte hydrolases on bacteria. I. Degradation of 14C-labeled Streptococcus and Staphylococcus by leukocyte lysates in vitro.
    J Infect Dis. 1974 May;129(5):528-37 PMID: 4823582
  14. THE ACTION OF HOT FORMAMIDE ON BACTERIAL CELL WALLS.
    Biochem J. 1965 Jun;95:876-82 PMID: 14342528
  15. Resistance of O-acetylated gonococcal peptidoglycan to human peptidoglycan-degrading enzymes.
    Infect Immun. 1983 Jun;40(3):903-11 PMID: 6406367
  16. Studies on the chemical structure of the streptococcal cell wall. I. The identification of a mucopeptide in the cell walls of groups A and A-variant streptococci.
    J Exp Med. 1961 Jul 1;114:127-40 PMID: 13754097
  17. Processing of streptococcal cell walls by rat macrophages and human monocytes in vitro.
    Infect Immun. 1977 Sep;17(3):591-8 PMID: 409678
  18. Reactivation of streptococcal cell wall-induced arthritis by homologous and heterologous cell wall polymers.
    Arthritis Rheum. 1985 Dec;28(12):1402-11 PMID: 3910050
  19. Radiologic analysis of arthritis in rats after systemic injection of streptococcal cell walls.
    Arthritis Rheum. 1979 Jan;22(1):25-35 PMID: 365186
  20. A modification of the Park and Johnson reducing sugar determination suitable for the assay of insoluble materials: its application to bacterial cell walls.
    Anal Biochem. 1968 Feb;22(2):260-8 PMID: 4966716
  21. Persistence of group a streptococcal cell walls related to chronic inflammation of rabbit dermal connective tissue.
    J Exp Med. 1967 Jun 1;125(6):1137-48 PMID: 5337778
  22. Relation of rheumatic-like cardiac lesions of the mouse to localization of group A streptococcal cell walls.
    J Exp Med. 1969 Jan 1;129(1):37-49 PMID: 5782771
  23. Modulation of complement fixation and the phlogistic capacity of group A, B, and D streptococci by human lysozyme acting on their cell walls.
    Infect Immun. 1986 Jun;52(3):803-11 PMID: 3086232
  24. Comparison of in vivo degradation of 125I-labeled peptidoglycan-polysaccharide fragments from group A and group D streptococci.
    Infect Immun. 1986 May;52(2):390-6 PMID: 3516872
  25. The autolytic enzyme system of Streptococcus faecalis. II. Partial characterization of the autolysin and its substrate.
    Biochemistry. 1967 Apr;6(4):1054-65 PMID: 4962053
  26. Polyarthritis in rats following the systemic injection of Lactobacillus casei cell walls in aqueous suspension.
    Arthritis Rheum. 1983 Oct;26(10):1259-65 PMID: 6414486
  27. Group A streptococci: localization in rabbits and guinea pigs following tissue injury.
    Science. 1969 Nov 28;166(3909):1161-3 PMID: 4186834
  28. Measurement of bacterial cell wall in tissues by solid-phase radioimmunoassay: correlation of distribution and persistence with experimental arthritis in rats.
    Infect Immun. 1982 Oct;38(1):127-35 PMID: 6754610
  29. O-acetyl groups in the cell wall of Streptococcus faecalis.
    J Biol Chem. 1958 Feb;230(2):949-59 PMID: 13525412
  30. Association of experimental chronic arthritis with the persistence of group A streptococcal cell walls in the articular tissue.
    J Bacteriol. 1967 Nov;94(5):1728-35 PMID: 4169223
  31. Arthropathic properties related to the molecular weight of peptidoglycan-polysaccharide polymers of streptococcal cell walls.
    Infect Immun. 1982 Mar;35(3):1003-10 PMID: 7040244
  32. Comparison of inflammatory reactions induced by intraarticular injection of bacterial cell wall polymers.
    Am J Pathol. 1986 Feb;122(2):323-34 PMID: 3511727
  33. Enzymatic deacetylation of N-acetylglucosamine residues in cell wall peptidoglycan.
    J Biochem. 1980 Aug;88(2):469-79 PMID: 6774970
  34. Bacterial cell wall composition, lysozyme resistance, and the induction of chronic arthritis in rats.
    Rheumatol Int. 1985;5(4):163-7 PMID: 3931201
  35. Arthropathic properties of gonococcal peptidoglycan fragments: implications for the pathogenesis of disseminated gonococcal disease.
    Infect Immun. 1986 May;52(2):600-8 PMID: 3084386
  36. Uveitis and arthritis induced by systemic injection of streptococcal cell walls.
    Invest Ophthalmol Vis Sci. 1986 Jun;27(6):921-5 PMID: 3519520
  37. Degradation of 14C-labeled streptococcal cell walls by egg white lysozyme and lysosomal enzymes.
    Infect Immun. 1976 May;13(5):1459-66 PMID: 773836
  38. Strain-related differences in lysozyme sensitivity and extent of O-acetylation of gonococcal peptidoglycan.
    Infect Immun. 1982 Aug;37(2):826-9 PMID: 6811442
  39. Treatment of experimental erosive arthritis in rats by injection of the muralytic enzyme mutanolysin.
    J Exp Med. 1984 Nov 1;160(5):1360-74 PMID: 6387033
  40. Structures and biological activities of peptidoglycans of Listeria monocytogenes and Propionibacterium acnes.
    J Biochem. 1982 Jul;92(1):23-33 PMID: 6811573
  41. The relation of experimental arthritis to the distribution of streptococcal cell wall fragments.
    Am J Pathol. 1980 Aug;100(2):383-402 PMID: 6996490
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1987-01-00
Pages
16-23
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC260274
Subset
IM
Grants
NIADDK NIH HHS · AM 25733 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]